Decentralized Science Project Aubrai Launches on Base to Tackle Science Funding's ‘Valley of Death’

2 hours ago

Longevity probe is intersecting with crypto done Aubrai, a decentralized subject (DeSci) and AI cause launched this week connected Base as portion of the Bio Protocol.

Decentralized science, oregon DeSci, uses blockchain and DAOs to money experiments directly, property recognition transparently, and crook probe outputs into tokenized assets that fto labs prolong themselves beyond philanthropy and accepted superior markets.

The AUBRAI token, launching connected Bio Protocol’s Launchpad, makes holders imperishable stakeholders successful the agent’s probe outputs, with governance rights implicit backing decisions and a stock successful revenues from commercialized discoveries

Built by VitaDAO and Bio Protocol with Aubrey de Grey’s LEV Foundation, Aubrai aims to span the “valley of death,” wherever long-horizon discoveries stall arsenic superior markets retreat and labs beryllium connected philanthropy.

de Grey is simply a biomedical gerontologist champion known for pioneering longevity probe done his Strategies for Engineered Negligible Senescence (SENS) model and for advocating that aging tin beryllium treated arsenic a curable condition.

“The consequences of accepted financing are a chronic backing gap, over-reliance connected philanthropy, and a ‘valley of death’ betwixt find and the clinic," de Grey told CoinDesk successful an interview.

"That’s wherefore we champion alternate mechanisms – DAOs, longevity-focused task funds, and DeSci platforms – which tin tolerate agelong horizons, align incentives astir societal benefit, and crowd-source risk,” de Grey said.

Aubrai’s attack combines de Grey’s unpublished laboratory information with onchain incentives. By drafting connected de Grey’s unpublished laboratory data, Aubrai gains entree to exclusive insights beyond nationalist literature, giving the cause a first-mover vantage successful generating novel, commercially applicable hypotheses successful longevity science.

The cause ingests experiments into a cognition graph, generates hypotheses, and routes them to token-holder votes for funding.

“We are already seeing the cause formulate intriguing caller hypotheses and urge adjacent steps,” de Grey said. “It’s the operation of agentic AI quality and adept quality quality that has the imaginable to dramatically velocity up breakthroughs successful the combat against aging.”

Once experiments are validated, discoveries are minted into IP-tokens that tin beryllium licensed to pharmaceutical oregon biotech firms, with revenues cycling backmost to researchers and contributors.

(Aubrai)

The strategy is already successful usage successful de Grey’s Robust Mouse Rejuvenation (RMR2) study, 1 of the largest rodent lifespan experiments ever attempted. Aubrai has suggested methodological tweaks and flagged dosing caveats that researchers had lone discovered aft weeks of manual review.

“Having the cause astatine our disposal has been transformative for our readying pipeline,” de Grey said, noting that RMR2 involves astir a twelve overlapping studies. “It identified points of information we had not yet encountered done literature, and it was proactive successful suggesting ways to circumvent foreseen limitations.”

For Paul Kohlhaas, Bio Protocol’s founder, Aubrai represents a turning constituent successful however subject tin beryllium organized and financed.

“Just arsenic Substack gave writers the quality to monetize extracurricular bequest media, Bio’s infrastructure tin crook scientists into the adjacent large creator economy,” helium said.

DeSci volition look challenges

While projects similar Aubrai and Bio Protocol show the imaginable of crypto superior beyond memecoins, tokenized intelligence spot is apt to pull regulatory scrutiny, and established pharmaceutical firms whitethorn hesitate to follow discoveries calved retired of decentralized collectives.

However, for a tract similar longevity, wherever breakthroughs often dice successful the abstraction betwixt aboriginal results and quality trials due to the fact that of a disinterested superior market, Aubrai offers an alternate path.

If it succeeds, it could show blockchain's imaginable to bash much than conscionable pump the adjacent memecoin. It could supply the infrastructure to accelerate probe itself, pushing the tract of longevity person to therapies that widen quality wellness span.

It would besides awesome that decentralized subject tin relation arsenic a viable marketplace alternate to the entrenched backing structures that person agelong constrained biomedical innovation.

View source